Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2025-12-25 @ 9:22 PM
NCT ID: NCT06091956
Description: None
Frequency Threshold: 0
Time Frame: Adverse events were collected from the first administration of study treatment through 30 days following the last administration of study treatment, approximately 28 weeks.
Study: NCT06091956
Study Brief: A Study of Deucravacitinib to Treat LPP and FFA
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Deucravacitinib Treatment for Lichen Planopilaris Subjects diagnosed with Lichen Planopilaris (LP) received Deucravacitinib for 24 weeks. Deucravacitinib: 6 milligram (mg) orally administrated, twice daily 0 None 1 11 11 11 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Diverticulitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Colon and Rectal Surgery SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Diverticulitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Rash on Neck SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Sore Throat/Lymph Nodes SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Pruritus SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Hair Loss SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Mouth Sore SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Acne SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Hand Dermatitis SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Rash/Acne SYSTEMATIC_ASSESSMENT Infections and infestations None View
Virus (cold/flu) SYSTEMATIC_ASSESSMENT General disorders None View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Bakers Cyst SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View
Canker Sore and Mouth Tenderness SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Canker Sores on Tongue SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Upper Respiratory Infection SYSTEMATIC_ASSESSMENT Infections and infestations None View
Fever SYSTEMATIC_ASSESSMENT General disorders None View
Gastrointestinal Pain after starting Protopic SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Inflammation of Gingiva SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Mouth Burning SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Mouth Pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Pain in Right Ear SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders None View